Bärbel Wilke
CEO at LKF at GBA Group Pharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Dr. Peter Seiler
Managing Director Healthcare with broad experience Strong background in global clinical trials Strong interpersonal and communication skills demonstrated by forming and leading LKF company Enjoys working in teams and interacting with both colleagues and customers Highly motivated, self-driven, works with highest level of honesty and integrity
Dr. Peter Seiler
Managing Director Healthcare with broad experience Strong background in global clinical trials Strong interpersonal and communication skills demonstrated by forming and leading LKF company Enjoys working in teams and interacting with both colleagues and customers Highly motivated, self-driven, works with highest level of honesty and integrity
Dr. Peter Seiler
Managing Director Healthcare with broad experience Strong background in global clinical trials Strong interpersonal and communication skills demonstrated by forming and leading LKF company Enjoys working in teams and interacting with both colleagues and customers Highly motivated, self-driven, works with highest level of honesty and integrity
Dr. Peter Seiler
Managing Director Healthcare with broad experience Strong background in global clinical trials Strong interpersonal and communication skills demonstrated by forming and leading LKF company Enjoys working in teams and interacting with both colleagues and customers Highly motivated, self-driven, works with highest level of honesty and integrity
Experience
-
GBA Group Pharma & Medical Devices
-
Germany
-
Public Health
-
1 - 100 Employee
-
CEO at LKF
-
Jun 1991 - Present
From early lead optimization and early preclinical stage to global clinical studies, GBA Group Pharma supports clients throughout the entire lifecycle with Central Laboratory, GMP Depots, EU GMP manufacturing site for labeling and packing and QP services, as well as late drug development and analytical services including import testing and QP batch release. From early lead optimization and early preclinical stage to global clinical studies, GBA Group Pharma supports clients throughout the entire lifecycle with Central Laboratory, GMP Depots, EU GMP manufacturing site for labeling and packing and QP services, as well as late drug development and analytical services including import testing and QP batch release.
-
-
-
Laboratorium für klinische Forschung
-
Kiel und Umgebung, Deutschland
-
CEO at LKF
-
May 1991 - Present
-
-
-
-
Medical-technical-assistant with managerial responsibilities, Project Manager
-
1991 - 1992
-
-
-
-
Medical-technical-assistant with managerial responsibilities
-
1983 - 1991
-
-
-
-
Medical-technical-assistant
-
1980 - 1983
-
-
Education
-
1978 - 1980
Hygiene-Institut Kiel
Medical-technical-assistant -
1976 - 1978
Specialist in internal medicine
Doctor's assistant
Community
